-
1
-
-
84961226869
-
Epidemiology and natural history of non-alcoholic fatty liver disease
-
Fazel, Y.; Koenig, A.B.; Sayiner, M.; Goodman, Z.D.; Younossi, Z.M. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism 2016, 65, 1017–1025. [CrossRef] [PubMed]
-
(2016)
Metabolism
, vol.65
, pp. 1017-1025
-
-
Fazel, Y.1
Koenig, A.B.2
Sayiner, M.3
Goodman, Z.D.4
Younossi, Z.M.5
-
2
-
-
84976479130
-
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
-
Younossi, Z.M.; Koenig, A.B.; Abdelatif, D.; Fazel, Y.; Henry, L.; Wymer, M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016, 64, 73–84. [CrossRef] [PubMed]
-
(2016)
Hepatology
, vol.64
, pp. 73-84
-
-
Younossi, Z.M.1
Koenig, A.B.2
Abdelatif, D.3
Fazel, Y.4
Henry, L.5
Wymer, M.6
-
3
-
-
84982106401
-
Metabolic aspects of adult patients with nonalcoholic fatty liver disease
-
Abenavoli, L.; Milic, N.; Di Renzo, L.; Preveden, T.; Medic-Stojanoska, M.; De Lorenzo, A. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World J. Gastroenterol. 2016, 22, 7006–7016. [CrossRef] [PubMed]
-
(2016)
World J. Gastroenterol
, vol.22
, pp. 7006-7016
-
-
Abenavoli, L.1
Milic, N.2
Di Renzo, L.3
Preveden, T.4
Medic-Stojanoska, M.5
De Lorenzo, A.6
-
4
-
-
0037129380
-
Nonalcoholic fatty liver disease
-
Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002, 346, 1221–1231. [CrossRef] [PubMed]
-
(2002)
N. Engl. J. Med
, vol.346
, pp. 1221-1231
-
-
Angulo, P.1
-
6
-
-
58849132440
-
Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C
-
Yatsuji, S.; Hashimoto, E.; Tobari, M.; Taniai, M.; Tokushige, K.; Shiratori, K. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J. Gastroenterol. Hepatol. 2009, 24, 248–254. [CrossRef] [PubMed]
-
(2009)
J. Gastroenterol. Hepatol
, vol.24
, pp. 248-254
-
-
Yatsuji, S.1
Hashimoto, E.2
Tobari, M.3
Taniai, M.4
Tokushige, K.5
Shiratori, K.6
-
7
-
-
55549106451
-
Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?
-
Guzman, G.; Brunt, E.M.; Petrovic, L.M.; Chejfec, G.; Layden, T.J.; Cotler, S.J. Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? Arch. Pathol. Lab. Med. 2008, 132, 1761–1766. [CrossRef] [PubMed]
-
(2008)
Arch. Pathol. Lab. Med
, vol.132
, pp. 1761-1766
-
-
Guzman, G.1
Brunt, E.M.2
Petrovic, L.M.3
Chejfec, G.4
Layden, T.J.5
Cotler, S.J.6
-
8
-
-
85026457212
-
Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies
-
Vizuete, J.; Camero, A.; Malakouti, M.; Garapati, K.; Gutierrez, J. Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies. J. Clin. Transl. Hepatol. 2017, 5, 67–75. [CrossRef] [PubMed]
-
(2017)
J. Clin. Transl. Hepatol
, vol.5
, pp. 67-75
-
-
Vizuete, J.1
Camero, A.2
Malakouti, M.3
Garapati, K.4
Gutierrez, J.5
-
9
-
-
43049170503
-
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
-
Ouyang, X.; Cirillo, P.; Sautin, Y.; McCall, S.; Bruchette, J.L.; Diehl, A.M.; Johnson, R.J.; Abdelmalek, M.F. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J. Hepatol. 2008, 48, 993–999. [CrossRef] [PubMed]
-
(2008)
J. Hepatol
, vol.48
, pp. 993-999
-
-
Ouyang, X.1
Cirillo, P.2
Sautin, Y.3
McCall, S.4
Bruchette, J.L.5
Diehl, A.M.6
Johnson, R.J.7
Abdelmalek, M.F.8
-
10
-
-
34848830434
-
Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study
-
Zelber-Sagi, S.; Nitzan-Kaluski, D.; Goldsmith, R.; Webb, M.; Blendis, L.; Halpern, Z.; Oren, R. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study. J. Hepatol. 2007, 47, 711–717. [CrossRef] [PubMed]
-
(2007)
J. Hepatol
, vol.47
, pp. 711-717
-
-
Zelber-Sagi, S.1
Nitzan-Kaluski, D.2
Goldsmith, R.3
Webb, M.4
Blendis, L.5
Halpern, Z.6
Oren, R.7
-
11
-
-
0037382071
-
Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis
-
Musso, G.; Gambino, R.; De Michieli, F.; Cassader, M.; Rizzetto, M.; Durazzo, M.; Faga, E.; Silli, B.; Pagano, G. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003, 37, 909–916. [CrossRef] [PubMed]
-
(2003)
Hepatology
, vol.37
, pp. 909-916
-
-
Musso, G.1
Gambino, R.2
De Michieli, F.3
Cassader, M.4
Rizzetto, M.5
Durazzo, M.6
Faga, E.7
Silli, B.8
Pagano, G.9
-
12
-
-
67049114700
-
Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol
-
Yasutake, K.; Nakamuta, M.; Shima, Y.; Ohyama, A.; Masuda, K.; Haruta, N.; Fujino, T.; Aoyagi, Y.; Fukuizumi, K.; Yoshimoto, T.; et al. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol. Scand. J. Gastroenterol. 2009, 44, 471–477. [CrossRef] [PubMed]
-
(2009)
Scand. J. Gastroenterol
, vol.44
, pp. 471-477
-
-
Yasutake, K.1
Nakamuta, M.2
Shima, Y.3
Ohyama, A.4
Masuda, K.5
Haruta, N.6
Fujino, T.7
Aoyagi, Y.8
Fukuizumi, K.9
Yoshimoto, T.10
-
13
-
-
84962661546
-
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
-
European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 2016, 64, 1388–1402. [CrossRef]
-
(2016)
J. Hepatol
, vol.1388-1402
, pp. 64
-
-
-
14
-
-
2342647592
-
Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans
-
Fontana, L.; Meyer, T.E.; Klein, S.; Holloszy, J.O. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc. Natl. Acad. Sci. USA. 2004, 101, 6659–6663. [CrossRef] [PubMed]
-
(2004)
Proc. Natl. Acad. Sci. USA
, vol.101
, pp. 6659-6663
-
-
Fontana, L.1
Meyer, T.E.2
Klein, S.3
Holloszy, J.O.4
-
15
-
-
85007618565
-
Non-pharmacological interventions in non-alcoholic fatty liver disease patients
-
Ratziu, V. Non-pharmacological interventions in non-alcoholic fatty liver disease patients. Liver Int. 2017, 37 (Suppl. 1), 90–96. [CrossRef] [PubMed]
-
(2017)
Liver Int
, vol.37
, pp. 90-96
-
-
Ratziu, V.1
-
16
-
-
34249668818
-
Epidemiology and natural history of NAFLD and NASH
-
Ong, J.P.; Younossi, Z.M. Epidemiology and natural history of NAFLD and NASH. Clin. Liver Dis. 2007, 11, 1–16. [CrossRef] [PubMed]
-
(2007)
Clin. Liver Dis
, vol.11
, Issue.1
, pp. 16
-
-
Ong, J.P.1
Younossi, Z.M.2
-
17
-
-
0036780582
-
Pathogenesis of steatohepatitis
-
Day, C.P. Pathogenesis of steatohepatitis. Best Pract. Res. Clin. Gastroenterol. 2002, 16, 663–678. [CrossRef] [PubMed]
-
(2002)
Best Pract. Res. Clin. Gastroenterol
, vol.16
, pp. 663-678
-
-
Day, C.P.1
-
18
-
-
84655169624
-
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
-
Rolo, A.P.; Teodoro, J.S.; Palmeira, C.M. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic. Biol. Med. 2012, 52, 59–69. [CrossRef] [PubMed]
-
(2012)
Free Radic. Biol. Med
, vol.52
, pp. 59-69
-
-
Rolo, A.P.1
Teodoro, J.S.2
Palmeira, C.M.3
-
19
-
-
84885911965
-
Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)
-
Takaki, A.; Kawai, D.; Yamamoto, K. Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int. J. Mol. Sci. 2013, 14, 20704–20728. [CrossRef] [PubMed]
-
(2013)
Int. J. Mol. Sci
, vol.14
, pp. 20704-20728
-
-
Takaki, A.1
Kawai, D.2
Yamamoto, K.3
-
20
-
-
84957812743
-
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
-
Buzzetti, E.; Pinzani, M.; Tsochatzis, E.A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016, 65, 1038–1048. [CrossRef] [PubMed]
-
(2016)
Metabolism
, vol.65
, pp. 1038-1048
-
-
Buzzetti, E.1
Pinzani, M.2
Tsochatzis, E.A.3
-
21
-
-
77956400005
-
Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance
-
Yang, L.; Li, P.; Fu, S.; Calay, E.S.; Hotamisligil, G.S. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 2010, 11, 467–478. [CrossRef] [PubMed]
-
(2010)
Cell Metab
, vol.11
, pp. 467-478
-
-
Yang, L.1
Li, P.2
Fu, S.3
Calay, E.S.4
Hotamisligil, G.S.5
-
22
-
-
84971290761
-
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
-
Hardy, T.; Oakley, F.; Anstee, Q.M.; Day, C.P. Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum. Annu. Rev. Pathol. 2016, 11, 451–496. [CrossRef] [PubMed]
-
(2016)
Annu. Rev. Pathol
, vol.11
, pp. 451-496
-
-
Hardy, T.1
Oakley, F.2
Anstee, Q.M.3
Day, C.P.4
-
23
-
-
33644524120
-
Apoptosis and necrosis in the liver: A tale of two deaths?
-
Malhi, H.; Gores, G.J.; Lemasters, J.J. Apoptosis and necrosis in the liver: A tale of two deaths? Hepatology 2006, 43, S31–S44. [CrossRef] [PubMed]
-
(2006)
Hepatology
, vol.43
, pp. S31-S44
-
-
Malhi, H.1
Gores, G.J.2
Lemasters, J.J.3
-
24
-
-
29244462334
-
Insulin signaling and the regulation of glucose transport
-
Chang, L.; Chiang, S.-H.; Saltiel, A.R. Insulin signaling and the regulation of glucose transport. Mol. Med. 2004, 10, 65–71. [CrossRef] [PubMed]
-
(2004)
Mol. Med
, vol.10
, pp. 65-71
-
-
Chang, L.1
Chiang, S.-H.2
Saltiel, A.R.3
-
25
-
-
84890469071
-
Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease
-
Martin-Dominguez, V.; Gonzalez-Casas, R.; Mendoza-Jimenez-Ridruejo, J.; Garcia-Buey, L.; Moreno-Otero, R. Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease. Rev. Esp. Enferm. Dig. 2013, 105, 409–420. [CrossRef] [PubMed]
-
(2013)
Rev. Esp. Enferm. Dig
, vol.105
, pp. 409-420
-
-
Martin-Dominguez, V.1
Gonzalez-Casas, R.2
Mendoza-Jimenez-Ridruejo, J.3
Garcia-Buey, L.4
Moreno-Otero, R.5
-
26
-
-
84859439842
-
The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance
-
Parnell, J.A.; Raman, M.; Rioux, K.P.; Reimer, R.A. The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. Liver Int. 2012, 32, 701–711. [CrossRef] [PubMed]
-
(2012)
Liver Int
, vol.32
, pp. 701-711
-
-
Parnell, J.A.1
Raman, M.2
Rioux, K.P.3
Reimer, R.A.4
-
27
-
-
33845901507
-
Microbial ecology: Human gut microbes associated with obesity
-
Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444, 1022–1023. [CrossRef] [PubMed]
-
(2006)
Nature
, vol.444
, pp. 1022-1023
-
-
Ley, R.E.1
Turnbaugh, P.J.2
Klein, S.3
Gordon, J.I.4
-
28
-
-
34249816158
-
Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease
-
Garner, C.E.; Smith, S.; de Lacy Costello, B.; White, P.; Spencer, R.; Probert, C.S.J.; Ratcliffe, N.M. Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2007, 21, 1675–1688. [CrossRef] [PubMed]
-
(2007)
FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol
, vol.21
, pp. 1675-1688
-
-
Garner, C.E.1
Smith, S.2
De Lacy Costello, B.3
White, P.4
Spencer, R.5
Probert, C.S.J.6
Ratcliffe, N.M.7
-
29
-
-
84879245628
-
Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease
-
Raman, M.; Ahmed, I.; Gillevet, P.M.; Probert, C.S.; Ratcliffe, N.M.; Smith, S.; Greenwood, R.; Sikaroodi, M.; Lam, V.; Crotty, P.; et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 2013, 11, 863–868. [CrossRef] [PubMed]
-
(2013)
Clin. Gastroenterol. Hepatol
, vol.11
, pp. 863-868
-
-
Raman, M.1
Ahmed, I.2
Gillevet, P.M.3
Probert, C.S.4
Ratcliffe, N.M.5
Smith, S.6
Greenwood, R.7
Sikaroodi, M.8
Lam, V.9
Crotty, P.10
-
30
-
-
37849028864
-
Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): A cross-sectional study
-
Allard, J.P.; Aghdassi, E.; Mohammed, S.; Raman, M.; Avand, G.; Arendt, B.M.; Jalali, P.; Kandasamy, T.; Prayitno, N.; Sherman, M.; et al. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): A cross-sectional study. J. Hepatol. 2008, 48, 300–307. [CrossRef] [PubMed]
-
(2008)
J. Hepatol
, vol.48
, pp. 300-307
-
-
Allard, J.P.1
Aghdassi, E.2
Mohammed, S.3
Raman, M.4
Avand, G.5
Arendt, B.M.6
Jalali, P.7
Kandasamy, T.8
Prayitno, N.9
Sherman, M.10
-
31
-
-
84916218639
-
Probiotics and Nonalcoholic Fatty liver Disease. Middle East
-
Eslamparast, T.; Eghtesad, S.; Hekmatdoost, A.; Poustchi, H. Probiotics and Nonalcoholic Fatty liver Disease. Middle East J. Dig. Dis. 2013, 5, 129–136. [PubMed]
-
(2013)
J. Dig. Dis
, vol.5
, pp. 129-136
-
-
Eslamparast, T.1
Eghtesad, S.2
Hekmatdoost, A.3
Poustchi, H.4
-
32
-
-
0036451169
-
The role of the liver in the response to LPS: Experimental and clinical findings
-
Jirillo, E.; Caccavo, D.; Magrone, T.; Piccigallo, E.; Amati, L.; Lembo, A.; Kalis, C.; Gumenscheimer, M. The role of the liver in the response to LPS: Experimental and clinical findings. J. Endotoxin Res. 2002, 8, 319–327. [CrossRef] [PubMed]
-
(2002)
J. Endotoxin Res
, vol.8
, pp. 319-327
-
-
Jirillo, E.1
Caccavo, D.2
Magrone, T.3
Piccigallo, E.4
Amati, L.5
Lembo, A.6
Kalis, C.7
Gumenscheimer, M.8
-
33
-
-
78649908827
-
The role of the gut microbiota in nonalcoholic fatty liver disease
-
Abu-Shanab, A.; Quigley, E.M.M. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 2010, 7, 691–701. [CrossRef] [PubMed]
-
(2010)
Nat. Rev. Gastroenterol. Hepatol
, vol.7
, pp. 691-701
-
-
Abu-Shanab, A.1
Quigley, E.M.M.2
-
34
-
-
0019776913
-
Endotoxin, reticuloendothelial function, and liver injury
-
Nolan, J.P. Endotoxin, reticuloendothelial function, and liver injury. Hepatology 1981, 1, 458–465. [CrossRef] [PubMed]
-
(1981)
Hepatology
, vol.1
, pp. 458-465
-
-
Nolan, J.P.1
-
35
-
-
78049522194
-
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
-
Tilg, H.; Moschen, A.R. Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology 2010, 52, 1836–1846. [CrossRef] [PubMed]
-
(2010)
Hepatology
, vol.52
, pp. 1836-1846
-
-
Tilg, H.1
Moschen, A.R.2
-
36
-
-
84973618679
-
Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials
-
Saez-Lara, M.J.; Robles-Sanchez, C.; Ruiz-Ojeda, F.J.; Plaza-Diaz, J.; Gil, A. Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials. Int. J. Mol. Sci. 2016, 17, 928. [CrossRef] [PubMed]
-
(2016)
Int. J. Mol. Sci
, vol.17
, pp. 928
-
-
Saez-Lara, M.J.1
Robles-Sanchez, C.2
Ruiz-Ojeda, F.J.3
Plaza-Diaz, J.4
Gil, A.5
-
37
-
-
84863103652
-
Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis
-
Ilan, Y. Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis. World J. Gastroenterol. 2012, 18, 2609–2618. [CrossRef] [PubMed]
-
(2012)
World J. Gastroenterol
, vol.18
, pp. 2609-2618
-
-
Ilan, Y.1
-
38
-
-
3042670090
-
TNFalpha release by the nonfat cells of human adipose tissue
-
Fain, J.N.; Bahouth, S.W.; Madan, A.K. TNFalpha release by the nonfat cells of human adipose tissue. Int. J. Obes. Relat. Metab. Disord. 2004, 28, 616–622. [CrossRef] [PubMed]
-
(2004)
Int. J. Obes. Relat. Metab. Disord
, vol.28
, pp. 616-622
-
-
Fain, J.N.1
Bahouth, S.W.2
Madan, A.K.3
-
39
-
-
84975523637
-
Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern
-
Wehmeyer, M.H.; Zyriax, B.-C.; Jagemann, B.; Roth, E.; Windler, E.; Schulze Zur Wiesch, J.; Lohse, A.W.; Kluwe, J. Nonalcoholic fatty liver disease is associated with excessive calorie intake rather than a distinctive dietary pattern. Medicine (Baltimore) 2016, 95, e3887. [CrossRef] [PubMed]
-
(2016)
Medicine (Baltimore)
, vol.95
-
-
Wehmeyer, M.H.1
Zyriax, B.-C.2
Jagemann, B.3
Roth, E.4
Windler, E.5
Schulze Zur Wiesch, J.6
Lohse, A.W.7
Kluwe, J.8
-
40
-
-
33747469042
-
How different is the dietary pattern in non-alcoholic steatohepatitis patients?
-
Cortez-Pinto, H.; Jesus, L.; Barros, H.; Lopes, C.; Moura, M.C.; Camilo, M.E. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin. Nutr. 2006, 25, 816–823. [CrossRef] [PubMed]
-
(2006)
Clin. Nutr
, vol.25
, pp. 816-823
-
-
Cortez-Pinto, H.1
Jesus, L.2
Barros, H.3
Lopes, C.4
Moura, M.C.5
Camilo, M.E.6
-
41
-
-
84864193026
-
Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD)
-
Volynets, V.; Kuper, M.A.; Strahl, S.; Maier, I.B.; Spruss, A.; Wagnerberger, S.; Konigsrainer, A.; Bischoff, S.C.; Bergheim, I. Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig. Dis. Sci. 2012, 57, 1932–1941. [CrossRef] [PubMed]
-
(2012)
Dig. Dis. Sci
, vol.57
, pp. 1932-1941
-
-
Volynets, V.1
Kuper, M.A.2
Strahl, S.3
Maier, I.B.4
Spruss, A.5
Wagnerberger, S.6
Konigsrainer, A.7
Bischoff, S.C.8
Bergheim, I.9
-
42
-
-
33845632821
-
Dietary habits and nutrient intake in non-alcoholic steatohepatitis
-
Toshimitsu, K.; Matsuura, B.; Ohkubo, I.; Niiya, T.; Furukawa, S.; Hiasa, Y.; Kawamura, M.; Ebihara, K.; Onji, M. Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition 2007, 23, 46–52. [CrossRef] [PubMed]
-
(2007)
Nutrition
, vol.23
, pp. 46-52
-
-
Toshimitsu, K.1
Matsuura, B.2
Ohkubo, I.3
Niiya, T.4
Furukawa, S.5
Hiasa, Y.6
Kawamura, M.7
Ebihara, K.8
Onji, M.9
-
43
-
-
84938957956
-
Dietary patterns are associated with prevalence of fatty liver disease in adults
-
Jia, Q.; Xia, Y.; Zhang, Q.; Wu, H.; Du, H.; Liu, L.; Wang, C.; Shi, H.; Guo, X.; Liu, X.; et al. Dietary patterns are associated with prevalence of fatty liver disease in adults. Eur. J. Clin. Nutr. 2015, 69, 914–921. [CrossRef] [PubMed]
-
(2015)
Eur. J. Clin. Nutr
, vol.69
, pp. 914-921
-
-
Jia, Q.1
Xia, Y.2
Zhang, Q.3
Wu, H.4
Du, H.5
Liu, L.6
Wang, C.7
Shi, H.8
Guo, X.9
Liu, X.10
-
44
-
-
85044283289
-
Association between rice, bread, and noodle intake and the prevalence of non-alcoholic fatty liver disease in Japanese middle-aged men and women
-
Tajima, R.; Kimura, T.; Enomoto, A.; Yanoshita, K.; Saito, A.; Kobayashi, S.; Masuda, K.; Iida, K. Association between rice, bread, and noodle intake and the prevalence of non-alcoholic fatty liver disease in Japanese middle-aged men and women. Clin. Nutr. 2016. [CrossRef] [PubMed]
-
(2016)
Clin. Nutr
-
-
Tajima, R.1
Kimura, T.2
Enomoto, A.3
Yanoshita, K.4
Saito, A.5
Kobayashi, S.6
Masuda, K.7
Iida, K.8
-
45
-
-
85016112250
-
Associations between Dietary Nutrient Intakes and Hepatic Lipid Contents in NAFLD Patients Quantified by (1)H-MRS and Dual-Echo MRI
-
Cheng, Y.; Zhang, K.; Chen, Y.; Li, Y.; Li, Y.; Fu, K.; Feng, R. Associations between Dietary Nutrient Intakes and Hepatic Lipid Contents in NAFLD Patients Quantified by (1)H-MRS and Dual-Echo MRI. Nutrients 2016, 8, 527. [CrossRef] [PubMed]
-
(2016)
Nutrients
, vol.8
, pp. 527
-
-
Cheng, Y.1
Zhang, K.2
Chen, Y.3
Li, Y.4
Li, Y.5
Fu, K.6
Feng, R.7
-
46
-
-
84994076466
-
Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus
-
Kobayashi, Y.; Tatsumi, H.; Hattori, M.; Sugiyama, H.; Wada, S.; Kuwahata, M.; Tanaka, S.; Kanemasa, K.; Sumida, Y.; Naito, Y.; et al. Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus. J. Clin. Biochem. Nutr. 2016, 59, 215–219. [CrossRef] [PubMed]
-
(2016)
J. Clin. Biochem. Nutr
, vol.59
, pp. 215-219
-
-
Kobayashi, Y.1
Tatsumi, H.2
Hattori, M.3
Sugiyama, H.4
Wada, S.5
Kuwahata, M.6
Tanaka, S.7
Kanemasa, K.8
Sumida, Y.9
Naito, Y.10
-
47
-
-
4444230462
-
A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: The women’s health study
-
Song, Y.; Manson, J.E.; Buring, J.E.; Liu, S. A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: The women’s health study. Diabetes Care 2004, 27, 2108–2115. [CrossRef] [PubMed]
-
(2004)
Diabetes Care
, vol.27
, pp. 2108-2115
-
-
Song, Y.1
Manson, J.E.2
Buring, J.E.3
Liu, S.4
-
48
-
-
84866981545
-
The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu
-
Shi, L.; Liu, Z.W.; Li, Y.; Gong, C.; Zhang, H.; Song, L.J.; Huang, C.Y.; Li, M. The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu. Biomed. Environ. Sci. 2012, 25, 383–391. [CrossRef] [PubMed]
-
(2012)
Biomed. Environ. Sci
, vol.25
, pp. 383-391
-
-
Shi, L.1
Liu, Z.W.2
Li, Y.3
Gong, C.4
Zhang, H.5
Song, L.J.6
Huang, C.Y.7
Li, M.8
-
49
-
-
69449085934
-
Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease
-
Collison, K.S.; Maqbool, Z.; Saleh, S.M.; Inglis, A.; Makhoul, N.J.; Bakheet, R.; Al-Johi, M.; Al-Rabiah, R.; Zaidi, M.Z.; Al-Mohanna, F.A. Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease. J. Lipid Res. 2009, 50, 1521–1537. [CrossRef] [PubMed]
-
(2009)
J. Lipid Res
, vol.50
, pp. 1521-1537
-
-
Collison, K.S.1
Maqbool, Z.2
Saleh, S.M.3
Inglis, A.4
Makhoul, N.J.5
Bakheet, R.6
Al-Johi, M.7
Al-Rabiah, R.8
Zaidi, M.Z.9
Al-Mohanna, F.A.10
-
50
-
-
84904760759
-
A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs. Healthy controls
-
Da Silva, H.E.; Arendt, B.M.; Noureldin, S.A.; Therapondos, G.; Guindi, M.; Allard, J.P. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs. healthy controls. J. Acad. Nutr. Diet. 2014, 114, 1181–1194. [CrossRef] [PubMed]
-
(2014)
J. Acad. Nutr. Diet
, vol.114
, pp. 1181-1194
-
-
Da Silva, H.E.1
Arendt, B.M.2
Noureldin, S.A.3
Therapondos, G.4
Guindi, M.5
Allard, J.P.6
-
51
-
-
14544275997
-
Origins and evolution of the Western diet: Health implications for the 21st century
-
Cordain, L.; Eaton, S.B.; Sebastian, A.; Mann, N.; Lindeberg, S.; Watkins, B.A.; O’Keefe, J.H.; Brand-Miller, J. Origins and evolution of the Western diet: Health implications for the 21st century. Am. J. Clin. Nutr. 2005, 81, 341–354. [PubMed]
-
(2005)
Am. J. Clin. Nutr
, vol.81
, pp. 341-354
-
-
Cordain, L.1
Eaton, S.B.2
Sebastian, A.3
Mann, N.4
Lindeberg, S.5
Watkins, B.A.6
O’Keefe, J.H.7
Brand-Miller, J.8
-
52
-
-
0344687175
-
Processed meat intake and incidence of Type 2 diabetes in younger and middle-aged women
-
Schulze, M.B.; Manson, J.E.; Willett, W.C.; Hu, F.B. Processed meat intake and incidence of Type 2 diabetes in younger and middle-aged women. Diabetologia 2003, 46, 1465–1473. [CrossRef] [PubMed]
-
(2003)
Diabetologia
, vol.46
, pp. 1465-1473
-
-
Schulze, M.B.1
Manson, J.E.2
Willett, W.C.3
Hu, F.B.4
-
53
-
-
85018648255
-
Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids
-
De Castro, G.S.; Calder, P.C. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. Clin. Nutr. 2017. [CrossRef] [PubMed]
-
(2017)
Clin. Nutr
-
-
De Castro, G.S.1
Calder, P.C.2
-
54
-
-
2942706241
-
Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease
-
Araya, J.; Rodrigo, R.; Videla, L.A.; Thielemann, L.; Orellana, M.; Pettinelli, P.; Poniachik, J. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin. Sci. (Lond.) 2004, 106, 635–643. [CrossRef] [PubMed]
-
(2004)
Clin. Sci. (Lond.)
, vol.106
, pp. 635-643
-
-
Araya, J.1
Rodrigo, R.2
Videla, L.A.3
Thielemann, L.4
Orellana, M.5
Pettinelli, P.6
Poniachik, J.7
-
55
-
-
79953126783
-
Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury
-
Kishino, T.; Ohnishi, H.; Ohtsuka, K.; Matsushima, S.; Urata, T.; Watanebe, K.; Honda, Y.; Mine, Y.; Matsumoto, M.; Nishikawa, K.; et al. Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury. Clin. Chem. Lab. Med. 2011, 49, 159–162. [CrossRef] [PubMed]
-
(2011)
Clin. Chem. Lab. Med
, vol.49
, pp. 159-162
-
-
Kishino, T.1
Ohnishi, H.2
Ohtsuka, K.3
Matsushima, S.4
Urata, T.5
Watanebe, K.6
Honda, Y.7
Mine, Y.8
Matsumoto, M.9
Nishikawa, K.10
-
56
-
-
84863430608
-
Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China
-
Zheng, J.-S.; Xu, A.; Huang, T.; Yu, X.; Li, D. Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China. Lipids 2012, 47, 549–556. [CrossRef] [PubMed]
-
(2012)
Lipids
, vol.47
, pp. 549-556
-
-
Zheng, J.-S.1
Xu, A.2
Huang, T.3
Yu, X.4
Li, D.5
-
57
-
-
84978245141
-
Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice
-
Marchesini, G.; Petta, S.; Dalle Grave, R. Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice. Hepatology 2016, 63, 2032–2043. [CrossRef] [PubMed]
-
(2016)
Hepatology
, vol.63
, pp. 2032-2043
-
-
Marchesini, G.1
Petta, S.2
Dalle Grave, R.3
-
58
-
-
33846821856
-
Nonalcoholic fatty liver disease: Predisposing factors and the role of nutrition
-
Cave, M.; Deaciuc, I.; Mendez, C.; Song, Z.; Joshi-Barve, S.; Barve, S.; McClain, C. Nonalcoholic fatty liver disease: Predisposing factors and the role of nutrition. J. Nutr. Biochem. 2007, 18, 184–195. [CrossRef] [PubMed]
-
(2007)
J. Nutr. Biochem
, vol.18
, pp. 184-195
-
-
Cave, M.1
Deaciuc, I.2
Mendez, C.3
Song, Z.4
Joshi-Barve, S.5
Barve, S.6
McClain, C.7
-
59
-
-
54049143271
-
Obesity and the Mediterranean diet: A systematic review of observational and intervention studies
-
Buckland, G.; Bach, A.; Serra-Majem, L. Obesity and the Mediterranean diet: A systematic review of observational and intervention studies. Obes. Rev. 2008, 9, 582–593. [CrossRef] [PubMed]
-
(2008)
Obes. Rev
, vol.9
, pp. 582-593
-
-
Buckland, G.1
Bach, A.2
Serra-Majem, L.3
-
60
-
-
52649094446
-
Adherence to Mediterranean diet and health status: Meta-analysis
-
Sofi, F.; Cesari, F.; Abbate, R.; Gensini, G.F.; Casini, A. Adherence to Mediterranean diet and health status: Meta-analysis. BMJ 2008, 337, a1344. [CrossRef] [PubMed]
-
(2008)
BMJ
, vol.337
-
-
Sofi, F.1
Cesari, F.2
Abbate, R.3
Gensini, G.F.4
Casini, A.5
-
61
-
-
84902358506
-
Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease
-
Kontogianni, M.D.; Tileli, N.; Margariti, A.; Georgoulis, M.; Deutsch, M.; Tiniakos, D.; Fragopoulou, E.; Zafiropoulou, R.; Manios, Y.; Papatheodoridis, G. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin. Nutr. 2014, 33, 678–683. [CrossRef] [PubMed]
-
(2014)
Clin. Nutr
, vol.33
, pp. 678-683
-
-
Kontogianni, M.D.1
Tileli, N.2
Margariti, A.3
Georgoulis, M.4
Deutsch, M.5
Tiniakos, D.6
Fragopoulou, E.7
Zafiropoulou, R.8
Manios, Y.9
Papatheodoridis, G.10
-
62
-
-
84917707317
-
Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet
-
Abenavoli, L.; Milic, N.; Peta, V.; Alfieri, F.; De Lorenzo, A.; Bellentani, S. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet. World J. Gastroenterol. 2014, 20, 16831–16840. [CrossRef] [PubMed]
-
(2014)
World J. Gastroenterol
, vol.20
, pp. 16831-16840
-
-
Abenavoli, L.1
Milic, N.2
Peta, V.3
Alfieri, F.4
De Lorenzo, A.5
Bellentani, S.6
-
63
-
-
84862885081
-
Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients
-
Bozzetto, L.; Prinster, A.; Annuzzi, G.; Costagliola, L.; Mangione, A.; Vitelli, A.; Mazzarella, R.; Longobardo, M.; Mancini, M.; Vigorito, C.; et al. Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. Diabetes Care 2012, 35, 1429–1435. [CrossRef] [PubMed]
-
(2012)
Diabetes Care
, vol.35
, pp. 1429-1435
-
-
Bozzetto, L.1
Prinster, A.2
Annuzzi, G.3
Costagliola, L.4
Mangione, A.5
Vitelli, A.6
Mazzarella, R.7
Longobardo, M.8
Mancini, M.9
Vigorito, C.10
-
64
-
-
84879136876
-
The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
-
Ryan, M.C.; Itsiopoulos, C.; Thodis, T.; Ward, G.; Trost, N.; Hofferberth, S.; O’Dea, K.; Desmond, P.V.; Johnson, N.A.; Wilson, A.M. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J. Hepatol. 2013, 59, 138–143. [CrossRef] [PubMed]
-
(2013)
J. Hepatol
, vol.59
, pp. 138-143
-
-
Ryan, M.C.1
Itsiopoulos, C.2
Thodis, T.3
Ward, G.4
Trost, N.5
Hofferberth, S.6
O’Dea, K.7
Desmond, P.V.8
Johnson, N.A.9
Wilson, A.M.10
-
65
-
-
85020127148
-
The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms
-
Zelber-Sagi, S.; Salomone, F.; Mlynarsky, L. The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. Liver Int. 2017, 37, 936–949. [CrossRef] [PubMed]
-
(2017)
Liver Int
, vol.37
, pp. 936-949
-
-
Zelber-Sagi, S.1
Salomone, F.2
Mlynarsky, L.3
-
66
-
-
77950952757
-
Olive oil and health: Summary of the II international conference on olive oil and health consensus report, Jaen and Cordoba (Spain) 2008
-
Lopez-Miranda, J.; Perez-Jimenez, F.; Ros, E.; De Caterina, R.; Badimon, L.; Covas, M.I.; Escrich, E.; Ordovas, J.M.; Soriguer, F.; Abia, R.; et al. Olive oil and health: Summary of the II international conference on olive oil and health consensus report, Jaen and Cordoba (Spain) 2008. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 284–294. [CrossRef] [PubMed]
-
(2010)
Nutr. Metab. Cardiovasc. Dis
, vol.20
, pp. 284-294
-
-
Lopez-Miranda, J.1
Perez-Jimenez, F.2
Ros, E.3
De Caterina, R.4
Badimon, L.5
Covas, M.I.6
Escrich, E.7
Ordovas, J.M.8
Soriguer, F.9
Abia, R.10
-
67
-
-
84949009777
-
Natural antioxidants for non-alcoholic fatty liver disease: Molecular targets and clinical perspectives
-
Salomone, F.; Godos, J.; Zelber-Sagi, S. Natural antioxidants for non-alcoholic fatty liver disease: Molecular targets and clinical perspectives. Liver Int. 2016, 36, 5–20. [CrossRef] [PubMed]
-
(2016)
Liver Int
, vol.36
, pp. 5-20
-
-
Salomone, F.1
Godos, J.2
Zelber-Sagi, S.3
-
68
-
-
84952637806
-
Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: Translational and clinical evidence
-
Federico, A.; Dallio, M.; Godos, J.; Loguercio, C.; Salomone, F. Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: Translational and clinical evidence. Transl. Res. 2016, 167, 116–124. [CrossRef] [PubMed]
-
(2016)
Transl. Res
, vol.167
, pp. 116-124
-
-
Federico, A.1
Dallio, M.2
Godos, J.3
Loguercio, C.4
Salomone, F.5
-
69
-
-
0035804277
-
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group
-
Sacks, F.M.; Svetkey, L.P.; Vollmer, W.M.; Appel, L.J.; Bray, G.A.; Harsha, D.; Obarzanek, E.; Conlin, P.R.; Miller, E.R., 3rd; Simons-Morton, D.G.; et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N. Engl. J. Med. 2001, 344, 3–10. [CrossRef] [PubMed]
-
(2001)
N. Engl. J. Med
, vol.344
, pp. 3-10
-
-
Sacks, F.M.1
Svetkey, L.P.2
Vollmer, W.M.3
Appel, L.J.4
Bray, G.A.5
Harsha, D.6
Obarzanek, E.7
Conlin, P.R.8
Miller, E.R.9
Simons-Morton, D.G.10
-
70
-
-
34547882082
-
Comparative review of diets for the metabolic syndrome: Implications for nonalcoholic fatty liver disease
-
Zivkovic, A.M.; German, J.B.; Sanyal, A.J. Comparative review of diets for the metabolic syndrome: Implications for nonalcoholic fatty liver disease. Am. J. Clin. Nutr. 2007, 86, 285–300. [PubMed]
-
(2007)
Am. J. Clin. Nutr
, vol.86
, pp. 285-300
-
-
Zivkovic, A.M.1
German, J.B.2
Sanyal, A.J.3
-
71
-
-
68149136676
-
Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: The insulin resistance atherosclerosis study
-
Liese, A.D.; Nichols, M.; Sun, X.; D’Agostino, R.B.J.; Haffner, S.M. Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: The insulin resistance atherosclerosis study. Diabetes Care 2009, 32, 1434–1436. [CrossRef] [PubMed]
-
(2009)
Diabetes Care
, vol.32
, pp. 1434-1436
-
-
Liese, A.D.1
Nichols, M.2
Sun, X.3
D’Agostino, R.B.J.4
Haffner, S.M.5
-
72
-
-
42449088045
-
Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women
-
Fung, T.T.; Chiuve, S.E.; McCullough, M.L.; Rexrode, K.M.; Logroscino, G.; Hu, F.B. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch. Intern. Med. 2008, 168, 713–720. [CrossRef] [PubMed]
-
(2008)
Arch. Intern. Med
, vol.168
, pp. 713-720
-
-
Fung, T.T.1
Chiuve, S.E.2
McCullough, M.L.3
Rexrode, K.M.4
Logroscino, G.5
Hu, F.B.6
-
73
-
-
84978676879
-
Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease
-
Hekmatdoost, A.; Shamsipour, A.; Meibodi, M.; Gheibizadeh, N.; Eslamparast, T.; Poustchi, H. Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease. Int. J. Food Sci. Nutr. 2016, 67, 1024–1029. [CrossRef] [PubMed]
-
(2016)
Int. J. Food Sci. Nutr
, vol.67
, pp. 1024-1029
-
-
Hekmatdoost, A.1
Shamsipour, A.2
Meibodi, M.3
Gheibizadeh, N.4
Eslamparast, T.5
Poustchi, H.6
-
74
-
-
84947483981
-
The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: A randomized clinical trial
-
Razavi Zade, M.; Telkabadi, M.H.; Bahmani, F.; Salehi, B.; Farshbaf, S.; Asemi, Z. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: A randomized clinical trial. Liver Int. 2016, 36, 563–571. [CrossRef] [PubMed]
-
(2016)
Liver Int
, vol.36
, pp. 563-571
-
-
Razavi Zade, M.1
Telkabadi, M.H.2
Bahmani, F.3
Salehi, B.4
Farshbaf, S.5
Asemi, Z.6
-
75
-
-
0037042466
-
Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: A randomised controlled trial
-
John, J.H.; Ziebland, S.; Yudkin, P.; Roe, L.S.; Neil, H.A.W. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: A randomised controlled trial. Lancet 2002, 359, 1969–1974. [CrossRef]
-
(2002)
Lancet
, vol.359
, pp. 1969-1974
-
-
John, J.H.1
Ziebland, S.2
Yudkin, P.3
Roe, L.S.4
Neil, H.A.W.5
-
76
-
-
84878700610
-
Increasing whole grain intake as part of prevention and treatment of nonalcoholic Fatty liver disease
-
Ross, A.B.; Godin, J.-P.; Minehira, K.; Kirwan, J.P. Increasing whole grain intake as part of prevention and treatment of nonalcoholic Fatty liver disease. Int. J. Endocrinol. 2013, 2013, 585876. [CrossRef] [PubMed]
-
(2013)
Int. J. Endocrinol
, vol.2013
-
-
Ross, A.B.1
Godin, J.-P.2
Minehira, K.3
Kirwan, J.P.4
-
77
-
-
84942767679
-
Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease
-
Gupta, V.; Mah, X.-J.; Garcia, M.C.; Antonypillai, C.; van der Poorten, D. Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease. World J. Gastroenterol. 2015, 21, 10621–10635. [CrossRef] [PubMed]
-
(2015)
World J. Gastroenterol
, vol.21
, pp. 10621-10635
-
-
Gupta, V.1
Mah, X.-J.2
Garcia, M.C.3
Antonypillai, C.4
Van Der Poorten, D.5
-
78
-
-
84978877720
-
Sugars, obesity, and cardiovascular disease: Results from recent randomized control trials
-
Rippe, J.M.; Angelopoulos, T.J. Sugars, obesity, and cardiovascular disease: Results from recent randomized control trials. Eur. J. Nutr. 2016, 55, 45–53. [CrossRef] [PubMed]
-
(2016)
Eur. J. Nutr
, vol.55
, pp. 45-53
-
-
Rippe, J.M.1
Angelopoulos, T.J.2
-
79
-
-
62449232030
-
Insulin sensitivity increase after calcium supplementation and change in intraplatelet calcium and sodium-hydrogen exchange in hypertensive patients with Type 2 diabetes
-
Pikilidou, M.I.; Lasaridis, A.N.; Sarafidis, P.A.; Befani, C.D.; Koliakos, G.G.; Tziolas, I.M.; Kazakos, K.A.; Yovos, J.G.; Nilsson, P.M. Insulin sensitivity increase after calcium supplementation and change in intraplatelet calcium and sodium-hydrogen exchange in hypertensive patients with Type 2 diabetes. Diabet. Med. 2009, 26, 211–219. [CrossRef] [PubMed]
-
(2009)
Diabet. Med
, vol.26
, pp. 211-219
-
-
Pikilidou, M.I.1
Lasaridis, A.N.2
Sarafidis, P.A.3
Befani, C.D.4
Koliakos, G.G.5
Tziolas, I.M.6
Kazakos, K.A.7
Yovos, J.G.8
Nilsson, P.M.9
-
80
-
-
34249111134
-
Magnesium and C-reactive protein in heart failure: An anti-inflammatory effect of magnesium administration?
-
Almoznino-Sarafian, D.; Berman, S.; Mor, A.; Shteinshnaider, M.; Gorelik, O.; Tzur, I.; Alon, I.; Modai, D.; Cohen, N. Magnesium and C-reactive protein in heart failure: An anti-inflammatory effect of magnesium administration? Eur. J. Nutr. 2007, 46, 230–237. [CrossRef] [PubMed]
-
(2007)
Eur. J. Nutr
, vol.46
, pp. 230-237
-
-
Almoznino-Sarafian, D.1
Berman, S.2
Mor, A.3
Shteinshnaider, M.4
Gorelik, O.5
Tzur, I.6
Alon, I.7
Modai, D.8
Cohen, N.9
-
81
-
-
0037340057
-
DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity
-
Lopes, H.F.; Martin, K.L.; Nashar, K.; Morrow, J.D.; Goodfriend, T.L.; Egan, B.M. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension 2003, 41, 422–430. [CrossRef] [PubMed]
-
(2003)
Hypertension
, vol.41
, pp. 422-430
-
-
Lopes, H.F.1
Martin, K.L.2
Nashar, K.3
Morrow, J.D.4
Goodfriend, T.L.5
Egan, B.M.6
-
82
-
-
78149272756
-
Prebiotic effects: Metabolic and health benefits
-
Roberfroid, M.; Gibson, G.R.; Hoyles, L.; McCartney, A.L.; Rastall, R.; Rowland, I.; Wolvers, D.; Watzl, B.; Szajewska, H.; Stahl, B.; et al. Prebiotic effects: Metabolic and health benefits. Br. J. Nutr. 2010, 104 (Suppl. 2), S1–S63. [CrossRef] [PubMed]
-
(2010)
Br. J. Nutr
, vol.104
, pp. SS1-S63
-
-
Roberfroid, M.1
Gibson, G.R.2
Hoyles, L.3
McCartney, A.L.4
Rastall, R.5
Rowland, I.6
Wolvers, D.7
Watzl, B.8
Szajewska, H.9
Stahl, B.10
-
83
-
-
23044434028
-
Effects of inulin-type fructans on lipid metabolism in man and in animal models
-
Beylot, M. Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br. J. Nutr. 2005, 93 (Suppl. 1), S163–S168. [CrossRef] [PubMed]
-
(2005)
Br. J. Nutr
, vol.93
, pp. S163-S168
-
-
Beylot, M.1
-
84
-
-
66849129539
-
Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults
-
Parnell, J.A.; Reimer, R.A. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 2009, 89, 1751–1759. [CrossRef] [PubMed]
-
(2009)
Am. J. Clin. Nutr
, vol.89
, pp. 1751-1759
-
-
Parnell, J.A.1
Reimer, R.A.2
-
85
-
-
19144365839
-
Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: Results of a pilot study
-
Daubioul, C.A.; Horsmans, Y.; Lambert, P.; Danse, E.; Delzenne, N.M. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: Results of a pilot study. Eur. J. Clin. Nutr. 2005, 59, 723–726. [CrossRef] [PubMed]
-
(2005)
Eur. J. Clin. Nutr
, vol.59
, pp. 723-726
-
-
Daubioul, C.A.1
Horsmans, Y.2
Lambert, P.3
Danse, E.4
Delzenne, N.M.5
-
86
-
-
84907960261
-
Very long chain omega-3 (N-3) fatty acids and human health
-
Calder, P.C. Very long chain omega-3 (n-3) fatty acids and human health. Eur. J. Lipid Sci. Technol. 2014, 116, 1280–1300. [CrossRef]
-
(2014)
Eur. J. Lipid Sci. Technol
, vol.116
, pp. 1280-1300
-
-
Calder, P.C.1
-
87
-
-
84880683621
-
Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease
-
Scorletti, E.; Byrne, C.D. Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease. Annu. Rev. Nutr. 2013, 33, 231–248. [CrossRef] [PubMed]
-
(2013)
Annu. Rev. Nutr
, vol.33
, pp. 231-248
-
-
Scorletti, E.1
Byrne, C.D.2
-
88
-
-
33646882162
-
Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: A pilot study
-
Capanni, M.; Calella, F.; Biagini, M.R.; Genise, S.; Raimondi, L.; Bedogni, G.; Svegliati-Baroni, G.; Sofi, F.; Milani, S.; Abbate, R.; et al. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: A pilot study. Aliment. Pharmacol. Ther. 2006, 23, 1143–1151. [CrossRef] [PubMed]
-
(2006)
Aliment. Pharmacol. Ther
, vol.23
, pp. 1143-1151
-
-
Capanni, M.1
Calella, F.2
Biagini, M.R.3
Genise, S.4
Raimondi, L.5
Bedogni, G.6
Svegliati-Baroni, G.7
Sofi, F.8
Milani, S.9
Abbate, R.10
-
89
-
-
38749115791
-
Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease
-
Spadaro, L.; Magliocco, O.; Spampinato, D.; Piro, S.; Oliveri, C.; Alagona, C.; Papa, G.; Rabuazzo, A.M.; Purrello, F. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig. Liver Dis. 2008, 40, 194–199. [CrossRef] [PubMed]
-
(2008)
Dig. Liver Dis
, vol.40
, pp. 194-199
-
-
Spadaro, L.1
Magliocco, O.2
Spampinato, D.3
Piro, S.4
Oliveri, C.5
Alagona, C.6
Papa, G.7
Rabuazzo, A.M.8
Purrello, F.9
-
90
-
-
63449137594
-
Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia
-
Zhu, F.-S.; Liu, S.; Chen, X.-M.; Huang, Z.-G.; Zhang, D.-W. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J. Gastroenterol. 2008, 14, 6395–6400. [CrossRef] [PubMed]
-
(2008)
World J. Gastroenterol
, vol.14
, pp. 6395-6400
-
-
Zhu, F.-S.1
Liu, S.2
Chen, X.-M.3
Huang, Z.-G.4
Zhang, D.-W.5
-
91
-
-
84904661185
-
No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial
-
Sanyal, A.J.; Abdelmalek, M.F.; Suzuki, A.; Cummings, O.W.; Chojkier, M. No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial. Gastroenterology 2014, 147, 377.el–384.e1. [CrossRef] [PubMed]
-
(2014)
Gastroenterology
, vol.147
, pp. el-e384
-
-
Sanyal, A.J.1
Abdelmalek, M.F.2
Suzuki, A.3
Cummings, O.W.4
Chojkier, M.5
-
92
-
-
84930268665
-
Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial
-
Nogueira, M.A.; Oliveira, C.P.; Ferreira Alves, V.A.; Stefano, J.T.; Rodrigues, L.S.D.R.; Torrinhas, R.S.; Cogliati, B.; Barbeiro, H.; Carrilho, F.J.; Waitzberg, D.L. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial. Clin. Nutr. 2016, 35, 578–586. [CrossRef] [PubMed]
-
(2016)
Clin. Nutr
, vol.35
, pp. 578-586
-
-
Nogueira, M.A.1
Oliveira, C.P.2
Ferreira Alves, V.A.3
Stefano, J.T.4
Rodrigues, L.S.D.R.5
Torrinhas, R.S.6
Cogliati, B.7
Barbeiro, H.8
Carrilho, F.J.9
Waitzberg, D.L.10
-
93
-
-
84961206930
-
Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study
-
Yari, Z.; Rahimlou, M.; Eslamparast, T.; Ebrahimi-Daryani, N.; Poustchi, H.; Hekmatdoost, A. Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study. Int. J. Food Sci. Nutr. 2016, 67, 461–469. [CrossRef] [PubMed]
-
(2016)
Int. J. Food Sci. Nutr
, vol.67
, pp. 461-469
-
-
Yari, Z.1
Rahimlou, M.2
Eslamparast, T.3
Ebrahimi-Daryani, N.4
Poustchi, H.5
Hekmatdoost, A.6
-
94
-
-
79955457155
-
Short-term weight loss and hepatic triglyceride reduction: Evidence of a metabolic advantage with dietary carbohydrate restriction
-
Browning, J.D.; Baker, J.A.; Rogers, T.; Davis, J.; Satapati, S.; Burgess, S.C. Short-term weight loss and hepatic triglyceride reduction: Evidence of a metabolic advantage with dietary carbohydrate restriction. Am. J. Clin. Nutr. 2011, 93, 1048–1052. [CrossRef] [PubMed]
-
(2011)
Am. J. Clin. Nutr
, vol.93
, pp. 1048-1052
-
-
Browning, J.D.1
Baker, J.A.2
Rogers, T.3
Davis, J.4
Satapati, S.5
Burgess, S.C.6
-
95
-
-
65249179010
-
Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction
-
Kirk, E.; Reeds, D.N.; Finck, B.N.; Mayurranjan, S.M.; Patterson, B.W.; Klein, S. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 2009, 136, 1552–1560. [CrossRef] [PubMed]
-
(2009)
Gastroenterology
, vol.136
, pp. 1552-1560
-
-
Kirk, E.1
Reeds, D.N.2
Finck, B.N.3
Mayurranjan, S.M.4
Patterson, B.W.5
Klein, S.6
-
96
-
-
79955107467
-
Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects
-
Haufe, S.; Engeli, S.; Kast, P.; Bohnke, J.; Utz, W.; Haas, V.; Hermsdorf, M.; Mahler, A.; Wiesner, S.; Birkenfeld, A.L.; et al. Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology 2011, 53, 1504–1514. [CrossRef] [PubMed]
-
(2011)
Hepatology
, vol.53
, pp. 1504-1514
-
-
Haufe, S.1
Engeli, S.2
Kast, P.3
Bohnke, J.4
Utz, W.5
Haas, V.6
Hermsdorf, M.7
Mahler, A.8
Wiesner, S.9
Birkenfeld, A.L.10
-
97
-
-
33846783170
-
The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: A pilot study
-
Tendler, D.; Lin, S.; Yancy, W.S.J.; Mavropoulos, J.; Sylvestre, P.; Rockey, D.C.; Westman, E.C. The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: A pilot study. Dig. Dis. Sci. 2007, 52, 589–593. [CrossRef] [PubMed]
-
(2007)
Dig. Dis. Sci
, vol.52
, pp. 589-593
-
-
Tendler, D.1
Lin, S.2
Yancy, W.S.J.3
Mavropoulos, J.4
Sylvestre, P.5
Rockey, D.C.6
Westman, E.C.7
-
98
-
-
78049278907
-
Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients
-
De Luis, D.A.; Aller, R.; Izaola, O.; Gonzalez Sagrado, M.; Conde, R. Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients. Nutr. Hosp. 2010, 25, 730–735. [PubMed]
-
(2010)
Nutr. Hosp
, vol.25
, pp. 730-735
-
-
De Luis, D.A.1
Aller, R.2
Izaola, O.3
Gonzalez Sagrado, M.4
Conde, R.5
-
99
-
-
85007277385
-
Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis
-
Katsagoni, C.N.; Georgoulis, M.; Papatheodoridis, G.V.; Panagiotakos, D.B.; Kontogianni, M.D. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis. Metabolism 2017, 68, 119–132. [CrossRef] [PubMed]
-
(2017)
Metabolism
, vol.68
, pp. 119-132
-
-
Katsagoni, C.N.1
Georgoulis, M.2
Papatheodoridis, G.V.3
Panagiotakos, D.B.4
Kontogianni, M.D.5
-
100
-
-
63349101854
-
VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice
-
Velayudham, A.; Dolganiuc, A.; Ellis, M.; Petrasek, J.; Kodys, K.; Mandrekar, P.; Szabo, G. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology 2009, 49, 989–997. [CrossRef] [PubMed]
-
(2009)
Hepatology
, vol.49
, pp. 989-997
-
-
Velayudham, A.1
Dolganiuc, A.2
Ellis, M.3
Petrasek, J.4
Kodys, K.5
Mandrekar, P.6
Szabo, G.7
-
101
-
-
84876725499
-
Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study
-
Wong, V.W.-S.; Won, G.L.-H.; Chim, A.M.-L.; Chu, W.C.-W.; Yeung, D.K.-W.; Li, K.C.-T.; Chan, H.L.-Y. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann. Hepatol. 2013, 12, 256–262. [PubMed]
-
(2013)
Ann. Hepatol
, vol.12
, pp. 256-262
-
-
Wong, V.W.-S.1
Won, G.L.-H.2
Chim, A.M.-L.3
Chu, W.C.-W.4
Yeung, D.K.-W.5
Li, K.C.-T.6
Chan, H.L.-Y.7
-
102
-
-
84918554640
-
Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial
-
Argo, C.K.; Patrie, J.T.; Lackner, C.; Henry, T.D.; de Lange, E.E.; Weltman, A.L.; Shah, N.L.; Al-Osaimi, A.M.; Pramoonjago, P.; Jayakumar, S.; et al. Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial. J. Hepatol. 2015, 62, 190–197. [CrossRef] [PubMed]
-
(2015)
J. Hepatol
, vol.62
, pp. 190-197
-
-
Argo, C.K.1
Patrie, J.T.2
Lackner, C.3
Henry, T.D.4
De Lange, E.E.5
Weltman, A.L.6
Shah, N.L.7
Al-Osaimi, A.M.8
Pramoonjago, P.9
Jayakumar, S.10
-
103
-
-
84919326883
-
Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease
-
Nabavi, S.; Rafraf, M.; Somi, M.H.; Homayouni-Rad, A.; Asghari-Jafarabadi, M. Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease. J. Dairy Sci. 2014, 97, 7386–7393. [CrossRef] [PubMed]
-
(2014)
J. Dairy Sci
, vol.97
, pp. 7386-7393
-
-
Nabavi, S.1
Rafraf, M.2
Somi, M.H.3
Homayouni-Rad, A.4
Asghari-Jafarabadi, M.5
-
104
-
-
84921439769
-
Mediterranean diet and non-alcoholic fatty liver disease
-
Trovato, F.M.; Catalano, D.; Martines, G.F.; Pace, P.; Trovato, G.M. Mediterranean diet and non-alcoholic fatty liver disease: The need of extended and comprehensive interventions. Clin. Nutr. 2015, 34, 86–88. [CrossRef] [PubMed]
-
(2015)
The Need of Extended and Comprehensive Interventions. Clin. Nutr
, vol.34
, pp. 86-88
-
-
Trovato, F.M.1
Catalano, D.2
Martines, G.F.3
Pace, P.4
Trovato, G.M.5
-
105
-
-
84924414123
-
Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease
-
Abenavoli, L.; Greco, M.; Nazionale, I.; Peta, V.; Milic, N.; Accattato, F.; Foti, D.; Gulletta, E.; Luzza, F. Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease. Expert Rev. Gastroenterol. Hepatol. 2015, 9, 519–527. [CrossRef] [PubMed]
-
(2015)
Expert Rev. Gastroenterol. Hepatol
, vol.9
, pp. 519-527
-
-
Abenavoli, L.1
Greco, M.2
Nazionale, I.3
Peta, V.4
Milic, N.5
Accattato, F.6
Foti, D.7
Gulletta, E.8
Luzza, F.9
-
106
-
-
4344593276
-
Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia
-
Hatzitolios, A.; Savopoulos, C.; Lazaraki, G.; Sidiropoulos, I.; Haritanti, P.; Lefkopoulos, A.; Karagiannopoulou, G.; Tzioufa, V.; Dimitrios, K. Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia. Indian J. Gastroenterol. 2004, 23, 131–134. [PubMed]
-
(2004)
Indian J. Gastroenterol
, vol.23
, pp. 131-134
-
-
Hatzitolios, A.1
Savopoulos, C.2
Lazaraki, G.3
Sidiropoulos, I.4
Haritanti, P.5
Lefkopoulos, A.6
Karagiannopoulou, G.7
Tzioufa, V.8
Dimitrios, K.9
-
107
-
-
41349102802
-
Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis
-
Tanaka, N.; Sano, K.; Horiuchi, A.; Tanaka, E.; Kiyosawa, K.; Aoyama, T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 2008, 42, 413–418. [CrossRef] [PubMed]
-
(2008)
J. Clin. Gastroenterol
, vol.42
, pp. 413-418
-
-
Tanaka, N.1
Sano, K.2
Horiuchi, A.3
Tanaka, E.4
Kiyosawa, K.5
Aoyama, T.6
-
108
-
-
49149084590
-
Effects of N-3 fatty acids on hepatic triglyceride content in humans
-
Vega, G.L.; Chandalia, M.; Szczepaniak, L.S.; Grundy, S.M. Effects of N-3 fatty acids on hepatic triglyceride content in humans. J. Investig. Med. 2008, 56, 780–785. [CrossRef] [PubMed]
-
(2008)
J. Investig. Med
, vol.56
, pp. 780-785
-
-
Vega, G.L.1
Chandalia, M.2
Szczepaniak, L.S.3
Grundy, S.M.4
-
109
-
-
84896770640
-
Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected
-
Scorletti, E.; Bhatia, L.; McCormick, K.G.; Clough, G.F.; Nash, K.; Calder, P.C.; Byrne, C.D. Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected]. Contemp. Clin. Trials 2014, 37, 301–311. [CrossRef] [PubMed]
-
(2014)
Contemp. Clin. Trials
, vol.37
, pp. 301-311
-
-
Scorletti, E.1
Bhatia, L.2
McCormick, K.G.3
Clough, G.F.4
Nash, K.5
Calder, P.C.6
Byrne, C.D.7
-
110
-
-
84921603820
-
Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis
-
Dasarathy, S.; Dasarathy, J.; Khiyami, A.; Yerian, L.; Hawkins, C.; Sargent, R.; McCullough, A.J. Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 2015, 49, 137–144. [CrossRef] [PubMed]
-
(2015)
J. Clin. Gastroenterol
, vol.49
, pp. 137-144
-
-
Dasarathy, S.1
Dasarathy, J.2
Khiyami, A.3
Yerian, L.4
Hawkins, C.5
Sargent, R.6
McCullough, A.J.7
-
111
-
-
84930851146
-
Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis
-
Li, Y.-H.; Yang, L.-H.; Sha, K.-H.; Liu, T.-G.; Zhang, L.-G.; Liu, X.-X. Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis. World J. Gastroenterol. 2015, 21, 7008–7013. [CrossRef] [PubMed]
-
(2015)
World J. Gastroenterol
, vol.21
, pp. 7008-7013
-
-
Li, Y.-H.1
Yang, L.-H.2
Sha, K.-H.3
Liu, T.-G.4
Zhang, L.-G.5
Liu, X.-X.6
-
112
-
-
14644435731
-
Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes
-
Petersen, K.F.; Dufour, S.; Befroy, D.; Lehrke, M.; Hendler, R.E.; Shulman, G.I. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 2005, 54, 603–608. [CrossRef] [PubMed]
-
(2005)
Diabetes
, vol.54
, pp. 603-608
-
-
Petersen, K.F.1
Dufour, S.2
Befroy, D.3
Lehrke, M.4
Hendler, R.E.5
Shulman, G.I.6
|